Younossi ZM - Search Results

1

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis.

Kowdley KV, Bowlus CL, Levy C, Mayo MJ, Pratt DS, Vuppalanchi R, Younossi ZM. Kowdley KV, et al. Among authors: younossi zm. Am J Gastroenterol. 2023 Feb 1;118(2):232-242. doi: 10.14309/ajg.0000000000002070. Epub 2022 Sep 21. Am J Gastroenterol. 2023. PMID: 36729104 Free PMC article.

2

Treatment of Crigler-Najjar type II with small-dose phenobarbital.

Younossi ZM, Foroozan P. Younossi ZM, et al. Dig Dis Sci. 1995 Mar;40(3):575. doi: 10.1007/BF02064372. Dig Dis Sci. 1995. PMID: 7895547 No abstract available.

3

Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated.

Koff JM, Younossi Z. Koff JM, et al. Am J Gastroenterol. 2004 Jun;99(6):972-3. doi: 10.1111/j.1572-0241.2004.40510.x. Am J Gastroenterol. 2004. PMID: 15180709 Review. No abstract available.

4

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O'Shea R, Carey WD, Ferguson R. Younossi ZM, et al. J Clin Gastroenterol. 2004 Sep;38(8):705-9. doi: 10.1097/01.mcg.0000135372.10846.2a. J Clin Gastroenterol. 2004. PMID: 15319656

5

Non-invasive markers for hepatic fibrosis.

Baranova A, Lal P, Birerdinc A, Younossi ZM. Baranova A, et al. Among authors: younossi zm. BMC Gastroenterol. 2011 Aug 17;11:91. doi: 10.1186/1471-230X-11-91. BMC Gastroenterol. 2011. PMID: 21849046 Free PMC article. Review.

6

Sofosbuvir for previously untreated chronic hepatitis C infection.

Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR, Jacobson IM, Kowdley KV, Nyberg L, Subramanian GM, Hyland RH, Arterburn S, Jiang D, McNally J, Brainard D, Symonds WT, McHutchison JG, Sheikh AM, Younossi Z, Gane EJ. Lawitz E, et al. N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23. N Engl J Med. 2013. PMID: 23607594 Free article. Clinical Trial.

7

A new comorbidity model for predicting mortality in patients with cirrhosis: does it work?

Younossi ZM, Henry L, Stepanova M. Younossi ZM, et al. Gastroenterology. 2014 Jan;146(1):19-24. doi: 10.1053/j.gastro.2013.11.026. Epub 2013 Nov 25. Gastroenterology. 2014. PMID: 24287302 No abstract available.

8

Hepatitis. Chronic HCV infection, diabetes and liver-related outcomes.

Henry L, Younossi Z. Henry L, et al. Nat Rev Gastroenterol Hepatol. 2014 Sep;11(9):520-1. doi: 10.1038/nrgastro.2014.122. Epub 2014 Jul 15. Nat Rev Gastroenterol Hepatol. 2014. PMID: 25023031

9

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials.

Younossi ZM, Stepanova M, Marcellin P, Afdhal N, Kowdley KV, Zeuzem S, Hunt SL. Younossi ZM, et al. Hepatology. 2015 Jun;61(6):1798-808. doi: 10.1002/hep.27724. Epub 2015 Mar 18. Hepatology. 2015. PMID: 25627448 Clinical Trial.

10

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir.

Younossi ZM, Stepanova M, Afdhal N, Kowdley KV, Zeuzem S, Henry L, Hunt SL, Marcellin P. Younossi ZM, et al. J Hepatol. 2015 Aug;63(2):337-45. doi: 10.1016/j.jhep.2015.03.014. Epub 2015 Mar 17. J Hepatol. 2015. PMID: 25795586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page